Alembic Pharma gets final USFDA nod for infection treatment drug

"Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Azithromycin Tablets USP, 600 mg," the drug firm said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2GFUfn7